Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7 | 5 | 5 | 5 | 6 |
| Accounts receivable | -15 | -6 | 0 | 21 | 40 |
| Accounts payable and accrued liabilities | 573 | 331 | -304 | N/A | N/A |
| Other Working Capital | 498 | 324 | -296 | 246 | -6 |
| Other Operating Activity | -5,724 | -7,001 | -3,939 | -2,164 | -1,172 |
| Operating Cash Flow | $-4,662 | $-6,346 | $-4,532 | $-1,893 | $-1,134 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -32 | -31 | -33 | -31 | -30 |
| Sale Of Investment | 32 | 30 | 33 | 31 | N/A |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $-30 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -89 | 0 | 63 |
| Common Stock Issued | 4,034 | 5,540 | 5,346 | 1,747 | 1,702 |
| Other Financing Activity | 71 | 1,320 | 53 | 4 | 31 |
| Financing Cash Flow | $4,105 | $6,860 | $5,310 | $1,750 | $1,796 |
| Beginning Cash Position | 1,829 | 1,241 | 566 | 672 | 18 |
| End Cash Position | 1,272 | 1,754 | 1,344 | 530 | 651 |
| Net Cash Flow | $-557 | $514 | $778 | $-142 | $633 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,662 | -6,346 | -4,532 | -1,893 | -1,134 |
| Free Cash Flow | -4,662 | -6,346 | -4,532 | -1,893 | -1,134 |